Navigation Links
Connectyx Technologies Holdings Group, Inc. to Begin Process to Become Fully Reporting and Up List to a Higher Exchange - As Stated on Wallstreetcorner.com
Date:7/23/2009

PALM CITY, Fla., July 23 /PRNewswire-FirstCall/ -- Connectyx Technologies Holdings Group, Inc. (Other OTC: CTYX) today announced that the Company's CEO Ronn Schuman stated in an interview on Wallstreetcorner.com that "Connectyx is to begin preparations necessary to file a Form 10 with the SEC in order to become a 'fully reporting' public company. If we are successful in achieving these goals, the Company will then seek to evaluate the prospects of applying to the OTC Bulletin Board."

During his interview with Larry Oakley, Mr. Schuman mentioned that the MedFlash(TM) continues to gain momentum and is currently being sold at 2,000 retail stores nationwide, and is also distributed through drug wholesalers to over 20,000 independent medical and pharmacy groups. Cardinal Health Care and AmerisourceBergen, two of the largest distribution companies of medical supplies to physician offices, hospitals, clinics, and pharmacies, are currently supplying the MedFlash(TM) for resale to consumers at specific locations of Kroger, Harris Teeter, Fred Meyer, QFC, Medicine Shoppes, Ralph's, HEB and many more.

"I think that Connectyx is at the right place at the right time - its market is beginning to unfold. Ronn Schuman plans to raise up to about $3 million for expansion & achieving a listing on the OTC BB as part of that process. Assuming that he is successful in doing that, I see his company's growth accelerating at a fast pace, because what his company needs to expand rapidly is some carefully directed advertising," stated Larry Oakley in his article.

"We are excited about the results Connectyx has achieved over the first six months of this year. If we are able to continue to increase our revenues while controlling or even reducing our costs further, we can count on achieving breakeven by the end of the fourth quarter of this year," stated Ronn Schuman, CEO of Connectyx Technologies Holdings
'/>"/>

SOURCE Connectyx Technologies Holdings Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Connectyx Looks to Establish Market Leadership with MedSync and MedFlash Product Line As Stated During Nationwide Teleconference
2. Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results
3. Connectyx Technologies Holdings Group, Inc. Increases Revenues by 45% and Reduces Expenses by 20% for the Second Quarter of 2009 Versus Second Quarter 2008
4. Connectyx Technologies Holdings Group, Inc. Signs an Agreement with Healthy Directions, LLC, Americas Largest Publisher of Alternative and Complementary Health Newsletters to Distribute its MedFlash EPHR
5. Connectyx Technologies Holdings Groups CEO Gives Shareholders a Summary of Events for First Half of 2009 and Announces Teleconference Call on July 9th to Discuss Future Strategy
6. Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference on July 9, 2009
7. Connectyx Technologies Signs Distributor to Serve the Vast South East Asia Market with its MedFlash Electronic Personal Health Record
8. Connectyx Partners with I-DENTI-FIED, Inc., to Add RFID Transponder Technology as Part of its MedFlash Personal Health Record
9. Connectyx CEO Announces Support of the Obama Plan to Invest in Health Information Technology
10. Connectyx to Hold National Press Event at National Press Club Tomorrow in Washington D.C. to Announce Launch of MedSync PHR Software
11. Connectyx to Hold National Press Event at National Press Club on May 13th in Washington D.C. to Announce Launch of MedSync PHR Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... The American Brain Tumor Association ... 2014-2016 Basic Research Fellowships and 2014-2015 Discovery Grant Awards. ... is seeding the field with talented, bright young investigators ... the causes, effects, diagnosis and treatment of brain tumors. ... based on the potential to advance the understanding and ...
(Date:8/27/2014)... the onset of a cancer defense mechanism known ... Cancer Center are leveraging it in a new ... cell death rather than survival. The novel treatment ... referred to as the "Trash Man" due to ... autophagy. Results from preclinical experiments suggest this experimental ...
(Date:8/27/2014)... Cash House 's contributions to Horizons ... upkeep of the shelter including new initiatives and a wide ... the lives of each youth who walk through their door. ... for youth ages 16-25. Not only does Horizons operate as ... for the youth who come through their doors. Horizons has ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 IQ ... supplements, today announced its continued support of the Cystic ... Formulations participated in a fundraising campaign led by TigerFitness.com ... of IQ Formulations’ sales were donated to the respected ... to a TigerFitness.com fundraiser to support Isla, a young ...
(Date:8/27/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... AND REGENERATIVE PRODUCTS , the global market for advanced ... by 2014-end to $42.2 billion by 2019, with a ... to 2019. New technologies and an increasingly older population ... market. , While there are many conventional and generally ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Cash House a Major Supporter of Horizons for Youth 2Health News:Cash House a Major Supporter of Horizons for Youth 3Health News:IQ Formulations Contributes Sizeable Donation to Cystic Fibrosis Foundation 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3
... to clinical ... trials ... company,focused on developing web-based integrated clinical trials management,systems (CTMS), announced ... research organization (CRO) and ECG core,lab Spacelabs Healthcare Clinical Trial ...
... (CALBIA), a non-profit membership organization providing information, education, ... injury, together with the Scarlett Law Group ... traumatic brain injury , invite you to participate ... medical/legal conferences dealing with traumatic brain injury: State ...
... Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies (December ... ... Horsham, PA (Vocus) October 28, 2008 -- The field of ... clinical trial safety and post-marketing pharmacovigilance becoming ever more critical ...
... "Protective Life Insurance Company," to their portfolio of available insurance ... ... October 28, 2008 -- TheHealthQuote continues to grow with the ... of top rated insurance companies - which currently spans over ...
... their prolonged seizures with the sedative propofol may be ... research presented at CHEST 2008, the 74th annual international ... (ACCP), shows that the use of propofol as an ... prolonged seizures that do not respond to initial treatment, ...
... 2008 Childhood obesity can lead to type 2 ... children and youth are likely to be obese as ... stroke and incur higher healthcare costs. In an article ... American Journal of Preventive Medicine, researchers report that ...
Cached Medicine News:Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 2Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 3Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 4Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 2Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 3Health News:DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks 2Health News:DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks 3Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 2Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 3Health News:Anti-seizure drug could be fatal 2Health News:Green neighborhoods may reduce childhood obesity 2
(Date:8/27/2014)... Aug. 27, 2014 Ambit Biosciences (Nasdaq: AMBI ... drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, ... Care Conference to be held at The New York Palace ... September 3-4, 2014. Alan Fuhrman , Ambit,s ... lead drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, ...
(Date:8/27/2014)... -- After the February 2014 launch of their new ... medical practices and management companies, Prime Clinical is reporting ... "The feedback has been great," says Director of ... of demos and new sign-ups is a reflection of ... of software features." Prime Clinical developed ...
(Date:8/27/2014)... 27, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be participating in the Morgan Stanley 2014 ... New York, New York , on Tuesday, ... CEO of Zimmer, will be presenting at 9:10 a.m. ... of Biomet, will join Mr. Dvorak for the Q&A ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
For the quantitative determination of Gamma Glutamyltransferase in serum or plasma...
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum and plasma...
The XCHO method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of cholesterol in serum and plasma....
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: